Electrocardiography

Electrocardiograms (ECG) are a primary cardiac diagnostic test that measures the electrical activity in heart to identify overall cardiac function, arrhythmias and areas of ischemia and infarct. Standard 12-lead ECG breaks the 3D structure of the heart into 12 zones, each showing the electrical activity in that specific area of the heart. This narrows down areas where there are issues with coronary artery disease or electrophysiology issues. Many ambulatory heart monitors and consumer-grade ECG monitors use fewer leads so are less specific as to cardiac conditions or location of abnormal heart rhythms, but can show an issue that requires further diagnostic testing or treatment.

CathVision’s ECGenius EP Recording System, a new solution designed to capture high-fidelity, low-noise electrocardiogram (ECG) recordings for the diagnosis and treatment of arrhythmias such as atrial fibrillation (AFib).

Heart rhythm specialists raise $7.2M to fund advances for FDA-cleared ECG system

The new funding all came from existing investors. “Reinvesting in the company demonstrates confidence in our innovation," CathVision's CEO said about the news. 

August 19, 2022
Ancora Heart AccuCinch Ventricular Restoration System heart failure FDA

Regulatory Roundup: FDA clears AI-powered Apple Watch competitor, grants breakthrough designation to new heart failure device

Ancora Heart received the FDA’s breakthrough device designation for its AccuCinch Ventricular Restoration System, a new minimally invasive transcatheter device designed for the treatment of heart failure.

July 25, 2022

Judge says Apple violated ECG patents, making U.S. import ban of Apple Watches a possibility

A judge from the U.S. International Trade Commission has said Apple violated multiple AliveCor patents. This story, however, is far from over.

June 30, 2022
Abbott’s FreeStyle Libre 3 glucose monitor gains FDA clearance

Regulatory Roundup: FDA clears 2 new devices, grants breakthrough designation to advanced AI model

Catch up on several recent FDA announcements, including an update on the agency's response to the COVID-19 pandemic. 

June 1, 2022
The Linq and Linq II implantable cardiac monitors at ACC22.

VIDEO: How to implant a Linq implantable cardiac monitor

The Medtronic Linq and Linq II implantable cardiac monitors (ICM) have become some of the most popular ICM devices on the market, partly because they are easy to insert.

April 28, 2022
Fitbit’s new algorithm for identifying signs of atrial fibrillation (AFib) has been cleared by the FDA. The photoplethysmography (PPG) algorithm was designed to passively evaluate a user’s heart rhythm while they are still or sleeping.

Fitbit’s latest AFib algorithm receives FDA clearance, will be available ‘soon’

The new algorithm was designed to evaluate a user's heart rhythm while they are still or even sleeping. 

April 12, 2022
Use of augmented reality and virtual reality to aid procedures and enhance clinician training is expected to see increasing use in the coming years in cardiology. Photo from Philips healthcare

VIDEO: 4 predictions on key cardiac technologies for the coming years

Mass General cardiologist and Harvard professor Ami Bhatt, MD, predicts upcoming paradigm shifts in cardiology over the next decade. 

March 24, 2022
Electrocardiograms analyzed by AI can offer information about mortality risk.

AI models capable of identifying RV, LV dysfunction in ECGs

Specialists used EHR data, imaging results and natural language processing to bring their advanced AI models to life. 

March 18, 2022

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup